These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 18226741)

  • 21. Risks in Randomized Controlled Trials: Role of Interim Analysis and Data Monitoring Committee.
    Naqvi HA
    J Coll Physicians Surg Pak; 2015 Aug; 25(8):557-9. PubMed ID: 26305298
    [No Abstract]   [Full Text] [Related]  

  • 22. Stopping trials for benefit can (sometimes) benefit patients.
    Pater JL; Goss P; Meyer R
    J Clin Oncol; 2008 Jun; 26(16):2787-8; author reply 2788. PubMed ID: 18509191
    [No Abstract]   [Full Text] [Related]  

  • 23. Keeping patients safe while avoiding bias in randomised trials.
    Freemantle N; Van de Werf F
    BMJ; 2012 May; 344():e3297. PubMed ID: 22586233
    [No Abstract]   [Full Text] [Related]  

  • 24. Bayesian interim analysis in clinical trials.
    Zhang X; Cutter G
    Contemp Clin Trials; 2008 Sep; 29(5):751-5. PubMed ID: 18589003
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Stopping clinical trials early for benefit: impact on estimation.
    Freidlin B; Korn EL
    Clin Trials; 2009 Apr; 6(2):119-25. PubMed ID: 19342463
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Should you join a clinical trial?
    Johns Hopkins Med Lett Health After 50; 2005 Mar; 17(1):6-7. PubMed ID: 15742482
    [No Abstract]   [Full Text] [Related]  

  • 27. From randomized controlled trials to observational studies.
    Silverman SL
    Am J Med; 2009 Feb; 122(2):114-20. PubMed ID: 19185083
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Quality monitoring in multi-central large sample acupuncture clinical trials].
    Zhao L; Li Y; Zhang FW; Guang H
    Zhongguo Zhen Jiu; 2008 Nov; 28(11):835-7. PubMed ID: 19055291
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Can trial sequential monitoring boundaries reduce spurious inferences from meta-analyses?
    Thorlund K; Devereaux PJ; Wetterslev J; Guyatt G; Ioannidis JP; Thabane L; Gluud LL; Als-Nielsen B; Gluud C
    Int J Epidemiol; 2009 Feb; 38(1):276-86. PubMed ID: 18824467
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Efficacy of probiotics in irritable bowel syndrome: a meta-analysis of randomized, controlled trials.
    Nikfar S; Rahimi R; Rahimi F; Derakhshani S; Abdollahi M
    Dis Colon Rectum; 2008 Dec; 51(12):1775-80. PubMed ID: 18465170
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Data safety and monitoring boards for African clinical trials.
    Lang T; Chilengi R; Noor RA; Ogutu B; Todd JE; Kilama WL; Targett GA
    Trans R Soc Trop Med Hyg; 2008 Dec; 102(12):1189-94. PubMed ID: 18644610
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Safety in paediatric clinical trials--a 7-year review.
    Sammons HM; Gray C; Hudson H; Cherrill J; Choonara I
    Acta Paediatr; 2008 Apr; 97(4):474-7. PubMed ID: 18307556
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Data monitoring committees and randomized clinical trials.
    Trachtman H; Caplan AL
    Kidney Int; 2019 Apr; 95(4):992. PubMed ID: 30904070
    [No Abstract]   [Full Text] [Related]  

  • 34. Clinician-trialist rounds: 23. When an RCT's Data Center Report drowns vital information in seas of data: where's Waldo?
    Pogue J; Sackett DL
    Clin Trials; 2014 Oct; 11(5):601-4. PubMed ID: 24958742
    [No Abstract]   [Full Text] [Related]  

  • 35. Data Monitoring Committees.
    Novack GD
    Ocul Surf; 2010 Jan; 8(1):40-3. PubMed ID: 20105406
    [No Abstract]   [Full Text] [Related]  

  • 36. Specific barriers to the conduct of randomized trials.
    Duley L; Antman K; Arena J; Avezum A; Blumenthal M; Bosch J; Chrolavicius S; Li T; Ounpuu S; Perez AC; Sleight P; Svard R; Temple R; Tsouderous Y; Yunis C; Yusuf S
    Clin Trials; 2008; 5(1):40-8. PubMed ID: 18283079
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Monitoring reportable events and unanticipated problems: the PHAROS and PREDICT studies of Huntington disease.
    Erwin C; Hersch S;
    IRB; 2007; 29(3):11-6. PubMed ID: 17847637
    [No Abstract]   [Full Text] [Related]  

  • 38. Clinical trials of multiple sclerosis therapies: improvements to demonstrate long-term patient benefit.
    Carroll WM
    Mult Scler; 2009 Aug; 15(8):951-8. PubMed ID: 19465446
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Importance of the randomized controlled trial in providing evidence of treatment efficacy.
    Farman AG
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2008 Apr; 105(4):410-1. PubMed ID: 18329577
    [No Abstract]   [Full Text] [Related]  

  • 40. Multicenter, randomized, controlled trials evaluating mortality in intensive care: doomed to fail?
    Ospina-Tascón GA; Büchele GL; Vincent JL
    Crit Care Med; 2008 Apr; 36(4):1311-22. PubMed ID: 18379260
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.